HIV prevention injection successful in South Africa trial

AllAfrica - Top Africa News July 1, 2024, 11:00 AM UTC

Summary: A pivotal trial in South Africa showed a highly effective HIV prevention injection, lenacapavir, providing six months of protection per shot. The injection outperformed prevention pills, with 0 new HIV infections in the lenacapavir group. Concerns remain about access and pricing, with hopes for quicker availability than previous treatments. Gilead aims to expedite regulatory approval and licensing for broader access.

Full article

Article metrics
Significance6.1
Scale8.0
Magnitude8.5
Novelty7.0
Actionability6.0
Immediacy7.5
Positivity9.0
Probability8.5
Credibility7.8

Timeline:

  1. [4.4]
    Biannual lenacapavir injection 100% effective in preventing HIV (News Karnataka)
    23h
    Source
  2. [5.1]
    UNAIDS urges global access to new HIV drug Lenacapavir (Marketscreener.com)
    4d

  3. [6.3]
    New HIV prevention drug lenacapavir shows 100% efficacy (ScienceAlert)
    5d

  4. [4.6]
    Biannual Lenacapavir injection 100% effective against HIV (WION)
    7d
    Source
  5. [5.8]
    Lenacapavir injection offers 100% HIV protection to young women (Hindustan Times)
    8d

  6. [5.2]
    HIV prevention drug lenacapavir safe and effective in trial (The East African)
    9d